From: DNA methylation: potential biomarker in Hepatocellular Carcinoma
Promoter microarray | |||||
Discovery method | HCC patients (n) | Validation method | Validated genes | Publication | Year |
MCAM-chip | 10 | Pyrosequencing | RASSF1A, p16, TBX4, MMP14, GNA14, SLC16A5, CCNA1 | Gao et al. [36] | 2008 |
 | 16 | Pyrosequencing | KLHL35, PAX5, PENK, SPDYA, LINE-1 | Shitani et al. [40] | 2012 |
DMH-chip | 21 | MSP | KLK10, OXGR1 | Lu et al. [37] | 2008 |
MeDIP-chip | 6 | MassArray | CYP24A1, DLX1, ZNF141, RASGRF2, ZNF382, TUBB6, NPR1, RRAD, RUNX3, LOX, JAKMIP1, SFRP4, DUSP4, PARQ8, CYP7B1 | Deng et al. [38] | 2010 |
 | 11 | Pyrosequencing | AKR1B10, CENPH, MMP9, MMP12, PAGE4, S100A5, MMP2, NUPR1 | Stefanska et al. [39] | 2011 |
Beadarray | Â | Â | Â | Â | Â |
Discovery method | HCC patients (n) | Validation method | Validated genes | Publication | Year |
GoldenGate | 20 | Methylight assay | APC | Archer et al. [49] | 2010 |
 | 38 | Pyrosequencing | RASSF1, GSTP1, APC, GABRA5, LINE-1 | Hernandez-Vargas et al. [43] | 2010 |
 | 45 | Bisulfite sequencing | ERG, HOXA9 | Hou et al. [47] | 2013 |
Infinium 27K | 3 | COBRA and bisulfite sequencing | WNK2, EMILIN2, TLX3, TM6SF1, TRIM58, HIST1H4F, GRASP | Tao et al. [44] | 2011 |
 | 62 | NIL | NIL | Yang et al. [118] | 2011 |
 | 13 | NIL | NIL | Ammerpohl et al. [48] | 2012 |
 | 62 | Pyrosequencing | CDKL2, STEAP4, HIST1H3G, CDKN2A, ZNF154 | Shen et al. [42] | 2012 |
 | 63 | Pyrosequencing | PER3 | Neumann et al. [50] | 2012 |
 | 71 | Pyrosequencing | NEFH, SMPD3 | Revill et al. [53] | 2013 |
Infinium 450K | 66 | NIL | NIL | Shen et al. [46] | 2013 |
 | 27 | Pyrosequencing | GSTP1, RASSF1, BMP4, DLGAP1, GPR35 | Song et al. [45] | 2013 |
 | 6 | Bisulfite sequencing | DBX2, THY1 | Zhang et.al. [41] | 2013 |